TrialJournal of inflammation research2021

Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive

Jinghui Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.